Author

Lara Gallucci

University of BristolORCID 0000-0001-6032-2675Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:metabolomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Iart Luca ShytajiD· 2 shared Aaron R. GoldmaniD· 1 shared Aijun Lin· 1 shared Alex Ap. Rosini SilvaiD· 1 shared Alex Quin· 1 shared Andrew D. DavidsoniD· 1 shared Beth Hoare· 1 shared Ester Cerdeira SabinoiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Iart Luca ShytajORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintFeb 25, 2026

FDXR Upregulation by p63/p73 is a Prognostic and Therapeutic Marker of HTLV-1-Associated Adult T Cell Leukemia/Lymphoma

Lara Gallucci, Maria Josephine, Yasunori Kogure…·Iart Luca Shytaj

This study identifies FDXR upregulation as a prognostic marker and therapeutic target in HTLV-1-associated ATL, showing its link to disease severity and sensitivity to fluorouracil.

DOI 10.64898/2026.02.25.707207

humanmetabolomics

𝕏 PostBluesky

MicrobiologyAntiviral ResearchPeer-reviewedNov 30, 2023

Broad-spectrum antiviral activity of clinically approved CYP3A inhibitors against pathogenic human coronaviruses in vitro

Lara Gallucci, James Bazire, Andrew D. Davidson, Iart Luca Shytaj

This study shows that cobicistat and ritonavir have antiviral activity against multiple SARS-CoV-2 variants and other human coronaviruses, with cobicistat being more potent.

4 citations

humanexperimental assay

𝕏 PostBluesky